Scarica l'app Stockscreener
74.63
0.40%
0.30
Precedente Chiudi:
$74.33
Aprire:
$75.79
Volume 24 ore:
75,410
Relative Volume:
0.38
Capitalizzazione di mercato:
$1.09B
Reddito:
$1.80M
Utile/perdita netta:
$1.76B
Rapporto P/E:
0.6289
EPS:
118.674
Flusso di cassa netto:
$-149.23M
1 W Prestazione:
-7.03%
1M Prestazione:
-9.61%
6M Prestazione:
+169.23%
1 anno Prestazione:
+449.15%
Intervallo 1D:
$74.09
$76.49
Intervallo di 1 settimana:
$70.72
$80.63
Portata 52W:
$10.80
$94.56
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Nome
Inhibrx Biosciences Inc
Settore
Industria
Telefono
(858) 795-4220
Indirizzo
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Compare INBX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
74.63 | 1.08B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | JMP Securities | Mkt Perform |
| 2024-01-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | Iniziato | SMBC Nikko | Outperform |
| 2021-09-21 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Inhibrx Biosciences Inc Borsa (INBX) Ultime notizie
Ewing sarcoma study of ozekibart takes stage at rare cancer congress - Stock Titan
How (INBX) Movements Inform Risk Allocation Models - Stock Traders Daily
INBX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight - The Malaysian Reserve
INBX Technical Analysis & ETF Price Forecast - Intellectia AI
INBX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Market Leaders: Is Inhibrx Biosciences Inc stock undervalued right nowWeekly Loss Report & Reliable Price Action Trade Plans - baoquankhu1.vn
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy - TipRanks
Chipmakers Recap: Is RNAC vulnerable to short sellersBond Market & Fast Moving Stock Trade Plans - baoquankhu1.vn
Trading Systems Reacting to (INBX) Volatility - Stock Traders Daily
Readystate Asset Management LP Acquires 143,324 Shares of Inhibrx Biosciences, Inc. $INBX - MarketBeat
Contrasting Immuneering (NASDAQ:IMRX) and Inhibrx Biosciences (NASDAQ:INBX) - Defense World
Inhibrx Biosciences, Inc. $INBX Shares Sold by Credit Industriel ET Commercial - MarketBeat
Will Inhibrx Biosciences Inc. be affected by tariffsJuly 2025 Intraday Action & Accurate Intraday Trade Tips - mfd.ru
Merger Talk: Is Inhibrx Biosciences Inc stock a hidden gem2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
What is the long term forecast for Inhibrx Biosciences Inc. stockEarnings Overview Summary & Pattern Based Trade Signal System - mfd.ru
Inhibrx Biosciences and Immuneering Compared in Financial Analysis - National Today
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 6.8%Here's What Happened - MarketBeat
Geopolitics Watch: Will Inhibrx Biosciences Inc stock recover after earningsWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Will Inhibrx Biosciences Inc. stock return to pre crisis levels2025 Trade Ideas & Verified Stock Trade Ideas - mfd.ru
Is Inhibrx Biosciences Inc. still a buy after recent gainsDay Trade & Stepwise Entry/Exit Trade Alerts - mfd.ru
Fund Flows: Whats the beta of Inhibrx Biosciences Inc stock2025 Market WrapUp & Reliable Breakout Forecasts - baoquankhu1.vn
Is Inhibrx Biosciences Inc. forming a bullish divergence2025 Sector Review & Daily Growth Stock Tips - mfd.ru
Morgan Stanley discloses 7.9% Inhibrx (INBX) stake in 13G filing - Stock Titan
How Inhibrx Biosciences Inc Com (INBX) Affects Rotational Strategy Timing - Stock Traders Daily
Does Inhibrx Biosciences Inc have strong EBITDA marginsJuly 2025 Pullbacks & Smart Money Movement Alerts - baoquankhu1.vn
Big Picture: Is Inhibrx Biosciences Inc stock undervalued right nowM&A Rumor & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Up 10.2%Still a Buy? - MarketBeat
Commit To Purchase Inhibrx Biosciences At $50, Earn 16.7% Annualized Using Options - Nasdaq
Insider Trends: Whats the MACD signal for Maris Tech Ltd Equity WarrantMarket Activity Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
(INBX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Inhibrx Biosciences Reports Promising Q3 2025 Results - MSN
S P Trends: Whats the outlook for SAIAs sectorDay Trade & High Accuracy Trade Alerts - baoquankhu1.vn
Aug Highlights: Is BILI benefiting from interest rate changesDividend Hike & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Sell Signal: Is Gorilla Technology Group Inc trading at a discountJuly 2025 Decliners & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Fed Watch: Will Hennessy Advisors Inc stock hit new highs in YEARLong Setup & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Responsive Playbooks and the INBX Inflection - Stock Traders Daily
Short Interest in Inhibrx Biosciences, Inc. (NASDAQ:INBX) Rises By 63.1% - MarketBeat
Inhibrx Biosciences (NASDAQ:INBX) Nasdaq Futures Science-Driven Path - Kalkine Media
Risk Hedge: Whats the beta of Inhibrx Biosciences Inc stockEarnings Miss & Fast Gain Swing Alerts - baoquankhu1.vn
Earnings Risk: Is Inhibrx Biosciences Inc stock a smart buy before Fed meetingJuly 2025 Highlights & Low Risk Profit Maximizing Plans - Bộ Nội Vụ
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 6.5%What's Next? - MarketBeat
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX) - Seeking Alpha
Is Inhibrx Biosciences Inc. stock attractive for passive investorsJuly 2025 Big Picture & Low Risk High Reward Trade Ideas - Улправда
Is Inhibrx Biosciences Inc. stock dividend yield sustainable2025 Biggest Moves & High Conviction Trade Alerts - Улправда
Can Inhibrx Biosciences Inc. stock deliver surprise earnings beatTake Profit & AI Powered Buy and Sell Recommendations - Улправда
Understanding the Setup: (INBX) and Scalable Risk - Stock Traders Daily
What drives Inhibrx Biosciences Inc stock priceEarnings Per Share Trends & Missed Nvidia? Don’t Miss This One - Early Times
Inhibrx Biosciences, Inc. (NASDAQ:INBX) Sees Large Decline in Short Interest - MarketBeat
Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts - Insider Monkey
Inhibrx Biosciences (NASDAQ:INBX) Trading Up 7.2% – Here’s Why - Defense World
Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):